Calian Group (TSE:CGY) Given New C$80.00 Price Target at Canaccord Genuity Group

Calian Group (TSE:CGY) had its price target boosted by Canaccord Genuity Group from C$63.00 to C$80.00 in a report issued on Friday morning,BayStreet.CA reports.

Several other research analysts also recently issued reports on CGY. Royal Bank Of Canada lifted their price target on Calian Group from C$58.00 to C$66.00 and gave the stock an “outperform” rating in a research note on Thursday, November 27th. Canadian Imperial Bank of Commerce raised their target price on shares of Calian Group from C$65.00 to C$76.00 in a report on Friday. Desjardins upped their price target on shares of Calian Group from C$59.00 to C$66.00 and gave the company a “buy” rating in a report on Thursday, November 27th. Finally, Ventum Financial raised their price objective on shares of Calian Group from C$62.00 to C$72.00 and gave the stock a “buy” rating in a research note on Tuesday, January 27th. Six equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of C$74.83.

Calian Group Price Performance

Shares of TSE:CGY opened at C$70.60 on Friday. The firm has a market capitalization of C$805.62 million, a price-to-earnings ratio of 40.11, a price-to-earnings-growth ratio of 2.50 and a beta of 0.70. The company has a debt-to-equity ratio of 39.54, a current ratio of 1.29 and a quick ratio of 1.20. The business’s 50 day simple moving average is C$60.38 and its 200-day simple moving average is C$54.12. Calian Group has a 12 month low of C$37.70 and a 12 month high of C$71.92.

Calian Group (TSE:CGY) last issued its quarterly earnings data on Thursday, February 12th. The company reported C$1.03 earnings per share (EPS) for the quarter. The firm had revenue of C$208.00 million during the quarter. Calian Group had a return on equity of 3.37% and a net margin of 1.50%. As a group, equities analysts forecast that Calian Group will post 4.9475219 earnings per share for the current fiscal year.

Calian Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 11th. Shareholders of record on Wednesday, March 11th will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Wednesday, February 25th. Calian Group’s dividend payout ratio (DPR) is currently 63.64%.

Trending Headlines about Calian Group

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
• Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
• Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
• Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
• Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

About Calian Group

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.